Lena Horvath
Innsbruck, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Skeletal Muscle as an Auto-, Para- and Endocrine Organ: The Role of Myokines in Muscle Metabolism and Other Metabolic Organs.
Journal: Physiological research
Published: January 09, 2026
The HLH-Risk-Calculator is a machine learning-based tool to predict course & mortality of secondary hemophagocytic lymphohistiocytosis.
Journal: Intensive care medicine
Published: October 07, 2025
Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report.
Journal: JTO clinical and research reports
Published: September 12, 2025
Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer.
Journal: Cancer cell
Published: February 25, 2025
Particular dysregulation of 'don't eat me' immune checkpoints in haemophagocytic lymphohistiocytosis.
Journal: British journal of haematology
Published: February 04, 2025
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Journal: Translational lung cancer research
Published: May 16, 2024
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC.
Journal: Trends in cancer
Published: November 03, 2023
Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students - an interventional study.
Journal: BMC medical education
Published: August 23, 2023
Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy.
Journal: Translational lung cancer research
Published: June 23, 2023
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Journal: Journal for immunotherapy of cancer
Published: October 17, 2022
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Journal: Thrombosis and haemostasis
Published: July 12, 2021
Last Updated: 09/26/2026